The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Well, based on 937m shares in issue, that reduction in the percentage held equates to about 1.5m shares - somewhat less than £15,000 worth. Are we sure the reduction from just above 4% to just below isn't the effect of some adjustment to the number of shares in issue? I find it hard to believe GC needed £15k.
But perhaps one of you is better at interpreting the form.
One school of thought has been that, if this is such a brilliant idea, why don’t those nearest to the coalface, and with the deepest pockets, cough up.
The RNS recognizes that Grosvenor may not be able to complete the financing. The following statement puts down a challenge to Grosvenor to “put up or shut up”
The Company has received indicative proposals from existing shareholders holding approximately 9.0 per cent. of the issued share capital willing to subscribe for their pro rata holding ("hold their corner") in an alternative equity fundraising of up to £5.0 million at a price of up to 1.25p per new ordinary share and an offer of alternative loan capital.
The RNS seems to cover most of the outstanding issues without subterfuge. Of course, the naysayers will continue to pour cold water over every announcement but I really don’t see what more we could have hoped for, short of last week’s lottery winner investing a tiny slice in Ironveld.
But perhaps this could mean that Christmas will come sooner rather than later. I prefer to remain optimistic.
Can somebody explain today's trading please? Aside from the in and out of a million shares we have 8 sales totalling just over £100 and two mighty buys of £1 each! Why are people wasting their time with these frivolous trades and do they actually mean something in the grand scheme of things?